Breaking News, Trials & Filings

Trials & Filings in Brief: Nov. 8, 2013

Advaxis, Discovery Laboratories, Peregrine, Pfizer, Pharming, Proteo, Santarus

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Preclinical Peregrine antibody shows combo-benefit in melanoma . . . read more Phase II Advaxis improves 18-month survival in cervical cancer . . . read more Elafin trial completes recruitment, treatment in CABG . . . read more Phase III Santarus, Pharming present Ruconest HAE results . . . read more Rapamune misses endpoint in renal function trial . . . read more Launches Discovery RDS treatment hits market . . . read more...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters